Cargando…
Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis
OBJECTIVE: Pancreatic cancer is portrayed to become the second leading cause of cancer-related death within the next years. Potentially complicating surgical resection emphasizes the importance of an accurate TNM classification. In particular, the failure to detect features for non-resectability has...
Autores principales: | Gassert, Felix G., Ziegelmayer, Sebastian, Luitjens, Johanna, Gassert, Florian T., Tollens, Fabian, Rink, Johann, Makowski, Marcus R., Rübenthaler, Johannes, Froelich, Matthias F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921086/ https://www.ncbi.nlm.nih.gov/pubmed/34837511 http://dx.doi.org/10.1007/s00330-021-08356-0 |
Ejemplares similares
-
(18)F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
por: Gassert, Felix G., et al.
Publicado: (2021) -
Cost-Effectiveness of Artificial Intelligence Support in Computed Tomography-Based Lung Cancer Screening
por: Ziegelmayer, Sebastian, et al.
Publicado: (2022) -
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis
por: Burian, Egon, et al.
Publicado: (2022) -
Diagnostic Workup for Patients with Solid Renal Masses: A Cost-Effectiveness Analysis
por: Runtemund, Jasmin, et al.
Publicado: (2022) -
Supplemental (18)F-FDG-PET/CT for Detection of Malignant Transformation of IPMN—A Model-Based Cost-Effectiveness Analysis
por: Bicu, Felix, et al.
Publicado: (2021)